Published in Antimicrob Agents Chemother on March 01, 1982
Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray. J Clin Microbiol (1986) 1.34
Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrob Agents Chemother (1990) 1.10
Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections. Antimicrob Agents Chemother (1986) 0.87
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrob Agents Chemother (1980) 9.02
In vitro activity of thienamycin. Antimicrob Agents Chemother (1978) 8.76
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity. Antimicrob Agents Chemother (1979) 5.81
Evaluation of a dispensing instrument (Dynatech MIC-2000) for preparing microtiter antibiotic plates and testing their potency during storage. Antimicrob Agents Chemother (1978) 4.37
In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother (1980) 3.90
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother (1981) 3.05
In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin. Antimicrob Agents Chemother (1980) 2.68
Adherence of bacteria to heart valves in vitro. J Clin Invest (1975) 3.74
Adherence of glucan-positive and glucan-negative streptococcal strains to normal and damaged heart valves. J Clin Invest (1978) 1.85
Increased pharyngeal bacterial colonization during viral illness. Arch Intern Med (1981) 1.70
Granulomatous hepatitis. Rev Infect Dis (1982) 1.55
Adrenal insufficiency in the acquired immunodeficiency syndrome. South Med J (1988) 1.38
Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria. Antimicrob Agents Chemother (1975) 1.14
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. AIDS (2000) 1.03
Comparative in-vitro activity of moxalactam and cefotaxime against isolates from blood culture. J Antimicrob Chemother (1981) 0.99
Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial. Arch Intern Med (1989) 0.94
Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections. Am J Med (1987) 0.93
Effects of molecular weight of dextran on the adherence of Streptococcus sanguis to damaged heart valves. Infect Immun (1980) 0.92
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med (1994) 0.85
Letter: Incidence of clindamycin-associated colitis. Ann Intern Med (1974) 0.82
The role of bacterial surface factors in the pathogenesis of infective endocarditis. Bol Asoc Med P R (1980) 0.81
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections. Chemotherapy (1989) 0.80
Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections. Am J Med (1985) 0.79
Septic arthritis of the sternoclavicular joint due to Citrobacter diversus. J Rheumatol (1983) 0.77
[Strongyloidiasis in the immunologically compromised patient]. Bol Asoc Med P R (1981) 0.76
[Cephalosporins. Therapeutic progress]. Bol Asoc Med P R (1980) 0.75
Dengue hemorrhagic shock in the western hemisphere. Trop Geogr Med (1979) 0.75
[Strongyloidiasis in the immunocompromised patient]. Bol Asoc Med P R (1980) 0.75
Focus on AIDS in Florida. J Fla Med Assoc (1988) 0.75
Clindamycin. A Trojan horse? Arch Otolaryngol (1975) 0.75
Use of tetracycline for the arthritis of jejunoileal bypass. J Rheumatol (1984) 0.75
Successful medical therapy of Rhodococcus equi pneumonia in a patient with HIV infection. Chest (1992) 0.75
Sexually transmitted diseases. Part II. Syphilis, chlamydias, herpes and scabies. Bol Asoc Med P R (1980) 0.75